Showing all posts written by Jessica Achtsam
She practices intellectual property law with an emphasis on U.S. and foreign patent prosecution and patent portfolio management in the medical device and biotechnology fields. Ms. Achtsam currently represents clients in a variety of technologies, including wound care devices and methods, ophthalmic devices and methods, and other medical device related technologies.
Before attending law school, Ms. Achtsam worked in research and development for Rules-Based Medicine, Inc. (now Myriad RBM, Inc.) in the area of biomarker testing development. During law school, Ms. Achtsam served as the Volume 20 Editor-in-Chief of the Texas Intellectual Property Law Journal.
On March 30, 2017, Boston Scientific announced an agreement to acquire Symetis SA, a privately-held Swiss company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices, for $435 million in cash.
On March 31, 2015, Orthofix International N.V. announced it entered into an 18-month option agreement to acquire eNeura, Inc. Orthofix’s website states that the focus of the company is on “improving patients’ lives by providing
According to a Boston Scientific Corp. press release from May 15, 2014, the company has entered into a definitive agreement to acquire the Interventional Division of Bayer AG for $415 million. The transaction is expected to close in the
On March 14, 2014, according to a press release, Smith & Nephew plc announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for the proposed merger of ArthroCare
On January 27, 2014, according to a press release, LifeCell Corporation acquired adipose Tissue Injector (aTI) technology for improved fat grafting procedures from the TauTona Group, a medical device incubator based in Menlo Park,
According to a Medtronic press release, Medtronic is acquiring TYRX, Inc. for an initial payment of $160 million plus potential future milestones. According to TYRX’s website, TYRX is the developer and manufacturer of “innovative,
On October 30, 2013, Zimmer Holdings, Inc. and Zimmer, Inc. filed a petition with the Patent Trial and Appeal Board requesting inter partes review of U.S. Patent No. 7,837,736, assigned to Bonutti Skeletal Innovations, LLC.
On August 19, St. Jude Medical, Inc. announced the acquisition of Endosense SA. The press release notes that St. Jude Medical has made an initial payment of approximately $170 million with additional cash payments of up to $161 million contingent
According to a company press release, Techne Corporation has agreed to acquire a 100% ownership stake of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. for $104 million in cash.
The press release identifies
Cynosure, Inc. announced last week the completion of its acquisition of Palomar Medical Technologies, Inc. According to the press release, Palomar was purchased in a cash and stock transaction valued at approximately $287 million.
Cardiocom files for Inter Partes Review of University of Rochester’s Patient Monitoring and Treatment Patent
The ‘985 patent is entitled “Methods